5[2]Sobey CG,Heiwtad DD,Faraci FM.Effect subarachnoid hemorrhage on cerebral vasodilatation in response to activation of ATP sensitive K+ channels in chronically hypertensive rats.Stroke,1997,28:392.
6[3]Luer M,Dujovny M,Slavi KV,et al.Regional cerebral oxygen saturation during intraarterial papaverone therapy for vasospasm case reports.Neurosurgery,1995,36:1003-1036.
7[4]Pluta RM,Thompson BG,Dowson TM,et al.Loss of metric oxide synthase immunoreactivity in cerebral vasospasm.J Neurosurg,1996,84:648.
8[5]Hiashima Y,Endo S,Kato R,et al.Prevention of cerebrovasospasm following subarachnoid hemorrhage in rabbits by the platelet activating factor antagonist,E5880.J Neurosurg,1996,84:826-830.
9[6]Sacco RL.Vascular disease.In:Merritt HH,Rowland LP.Textbook of Neurology.10thed.Baltimore:Williams ＆ Wilkins,2000.217-274.
10[7]Anlen GS,Ahn HS,Preziosi TJ,et al.Cerebral arterial spasm:A controlled trial of nimodipine in patients with subarachnoid hemorrhage.N Engl Med,1983,308:619-624.
